Different Immunological Phenotypes Associated with Preserved CD4+ T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Gaardbo, Julie Christine ^a   Hartling, Hans J ^a   Ronit, Andreas ^a   Thorsteinsson, Kristina ^b   Madsen, Hans Ole ^a   Springborg, Karoline ^a   Gjerdrum, Lise Mette Rahbek ^a   Birch, Carsten ^a   Laye, Matthew ^a   Ullum, Henrik ^a   Andersen, Åse Bengaard ^c   Nielsen, Susanne Dam ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7 RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DESTRUCTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RECEPTOR DENSITY; SENESCENCE; TELOMERE; TONSIL; VIREMIA; VIRUS LOAD;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LYMPHOID TISSUE; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-7; TELOMERE; VIRAL LOAD;

EID: 84877792432     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063744     Document Type: Article

References (44)

1. Gaardbo JC, Hartling HJ, Gerstoft J, Nielsen SD, (2012) Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors. AIDS Res Treat 2012: 161584 10.1155/2012/161584 [doi].
2. Blankson JN, Bailey JR, Thayil S, Yang HC, Lassen K, et al. (2007) Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol 81: 2508-2518 JVI.02165-06 [pii];10.1128/JVI.02165-06 [doi].
3. Broussard SR, Staprans SI, White R, Whitehead EM, Feinberg MB, et al. (2001) Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J Virol 75: 2262-2275 10.1128/JVI.75.5.2262-2275.2001 [doi].
4. Kaur A, Grant RM, Means RE, McClure H, Feinberg M, et al. (1998) Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J Virol 72: 9597-9611.
5. Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sorensen TU, et al. (2001) Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 98: 398-404.
6. Sottini A, Ghidini C, Zanotti C, Chiarini M, Caimi L, et al. (2010) Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation. Clin Immunol 136: 217-227 S1521-6616(10)00537-1 [pii];10.1016/j.clim.2010.04.005 [doi].
7. Laye MJ, Solomon TP, Karstoft K, Pedersen KK, Nielsen SD, et al. (2012) Increased shelterin mRNA expression in peripheral blood mononuclear cells and skeletal muscle following an ultra-long-distance running event. J Appl Physiol 112: 773-781 japplphysiol.00997.2011 [pii];10.1152/japplphysiol.00997.2011 [doi].
8. Mozos A, Garrido M, Carreras J, Plana M, Diaz A, et al. (2007) Redistribution of FOXP3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients. J Acquir Immune Defic Syndr 46: 529-537.
9. Marchetti G, Riva A, Cesari M, Bellistri GM, Gianelli E, et al. (2009) HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. HIV Med 10: 422-431 HIV710 [pii];10.1111/j.1468-1293.2009.00710.x [doi].
10. Carbone J, Gil J, Benito JM, Fernandez-Cruz E, (2003) Decreased expression of activation markers on CD4 T lymphocytes of HIV-infected long-term non-progressors. AIDS 17: 133-134 10.1097/01.aids.0000042932.55529.59 [doi];00002030-200301030-00021 [pii].
11. Zanussi S, Simonelli C, D'Andrea M, Caffau C, Clerici M, et al. (1996) CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin Exp Immunol 105: 220-224.
12. Richardson MW, Sverstiuk AE, Gracely EJ, Hendel H, Khalili K, et al. (2003) T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection. AIDS 17: 915-917 10.1097/01.aids.0000050839.06065.0e [doi].
13. Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, et al. (2009) Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis 200: 1714-1723 10.1086/646609 [doi].
14. Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, et al. (2000) Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 6: 1036-1042 10.1038/79549 [doi].
15. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, et al. (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695 10.1038/25374 [doi].
16. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, et al. (1997) Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277: 112-116.
17. Potter SJ, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, et al. (2007) Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J Virol 81: 13904-13915 JVI.01401-07 [pii];10.1128/JVI.01401-07 [doi].
18. Yang Y, Al-Mozaini M, Buzon MJ, Beamon J, Ferrando-Martinez S, et al. (2012) CD4 T-cell regeneration in HIV-1 elite controllers. AIDS 26: 701-706 10.1097/QAD.0b013e3283519b22 [doi].
19. Ruiz-Mateos E, Ferrando-Martinez S, Machmach K, Viciana P, Pacheco YM et al. (2010) High levels of CD57+. Curr HIV Res 8: 471-481. ABS-93 [pii].
20. Westrop SJ, Qazi NA, Pido-Lopez J, Nelson MR, Gazzard B, et al. (2009) Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllers. PLoS One 4: e5474 10.1371/journal.pone.0005474 [doi].
21. Park LS, Friend DJ, Schmierer AE, Dower SK, Namen AE, (1990) Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line. J Exp Med 171: 1073-1089.
22. Rethi B, Fluur C, Atlas A, Krzyzowska M, Mowafi F et al. (2005) Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 19: 2077-2086. 00002030-200512020-00003 [pii].
23. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, et al. (1997) Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 16: 83-92.
24. Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, et al. (2003) Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17: 1881-1888 10.1097/01.aids.0000076311.76477.6e [doi].
25. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, et al. (1992) Programmed death of T cells in HIV-1 infection. Science 257: 217-219.
26. Palmer BE, Blyveis N, Fontenot AP, Wilson CC (2005) Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J Immunol 175: 8415-8423. 175/12/8415 [pii].
27. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, et al. (2008) Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 197: 126-133 10.1086/524143 [doi].
28. Owen RE, Heitman JW, Hirschkorn DF, Lanteri MC, Biswas HH, et al. (2010) HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS 24: 1095-1105 10.1097/QAD.0b013e3283377a1e [doi].
29. Kamya P, Tsoukas CM, Boulet S, Routy JP, Thomas R, et al. (2011) T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers. AIDS Res Ther 8: 20 1742-6405-8-20 [pii];10.1186/1742-6405-8-20 [doi].
30. Bello G, Velasco-de-Castro CA, Bongertz V, Rodrigues CA, Giacoia-Gripp CB, et al. (2009) Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1. J Med Virol 81: 1681-1690 10.1002/jmv.21565 [doi].
31. Franceschi C, Franceschini MG, Boschini A, Trenti T, Nuzzo C, et al. (1997) Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors. Cell Death Differ 4: 815-823 4400305 [pii];10.1038/sj.cdd.4400305 [doi].
32. Schweneker M, Favre D, Martin JN, Deeks SG, McCune JM (2008) HIV-induced changes in T cell signaling pathways. J Immunol 180: 6490-6500. 180/10/6490 [pii].
33. Cawthon RM, (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47.
34. Wong JM, Collins K, (2003) Telomere maintenance and disease. Lancet 362: 983-988 S0140-6736(03)14369-3 [pii];10.1016/S0140-6736(03)14369-3 [doi].
35. Wolthers KC, Bea G, Wisman A, Otto SA, de Roda Husman AM, et al. (1996) T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover. Science 274: 1543-1547.
36. Whittall T, Peters B, Rahman D, Kingsley CI, Vaughan R, et al. (2011) Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control. Clin Exp Immunol 166: 208-217 10.1111/j.1365-2249.2011.04463.x [doi].
37. Vieillard V, Fausther-Bovendo H, Samri A, Debre P, (2010) Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers. J Acquir Immune Defic Syndr 53: 564-573 10.1097/QAI.0b013e3181d0c5b4 [doi].
38. Ho Tsong FR, Khatissian E, Monceaux V, Cumont MC et al. (2005) Disease progression in macaques with low SIV replication levels: on the relevance of TREC counts. AIDS 19: 663-673. 00002030-200504290-00003 [pii].
39. Hatzakis A, Touloumi G, Karanicolas R, Karafoulidou A, Mandalaki T, et al. (2000) Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet 355: 599-604 S0140-6736(99)10311-8 [pii];10.1016/S0140-6736(99)10311-8 [doi].
40. Lefrere JJ, Morand-Joubert L, Mariotti M, Bludau H, Burghoffer B, et al. (1997) Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 90: 1133-1140.
41. Rodes B, Toro C, Paxinos E, Poveda E, Martinez-Padial M (2004) Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS 18: 1109-1116. 00002030-200405210-00004 [pii].
42. Kitchen CR, Hunt P, Lee S, Toyama J, Sinclair Eet al. Immunologic Profile Distinguishes Aviremic HIV+ Adults, Conference on Retroviruses and Opportunistic Infections.CROI 2013, paper #73.
43. Sanchez J (2013) Persistent Abnormalities of Lymphoid Structures in HIV Viremic Controllers, Conference on Retroviruses and Opportunistic Infections., CROI 2013 paper #74.
44. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen OJ, et al. (1995) Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332: 209-216 10.1056/NEJM199501263320402 [doi].